首页> 美国卫生研究院文献>International Journal of Oncology >miR-15a represses cancer cell migration and invasion under conditions of hypoxia by targeting and downregulating Bcl-2 expression in human osteosarcoma cells
【2h】

miR-15a represses cancer cell migration and invasion under conditions of hypoxia by targeting and downregulating Bcl-2 expression in human osteosarcoma cells

机译:miR-15a通过靶向和下调人骨肉瘤细胞中的Bcl-2表达来抑制缺氧条件下的癌细胞迁移和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Osteosarcoma is a common, high-risk primary bone malignancy that mostly affects the younger population. There has been no marked improvement in the clinical outcomes of osteosarcoma patients to date, and cancer recurrence and metastasis are common in high-grade osteosarcoma. Therefore, identifying new biomarkers and novel therapeutic targets is crucial for improving the prognosis of osteosarcoma patients. In the present study, the MG63 human osteosarcoma cell line was employed to examine the role of microRNA (miR)-15a in regulating cellular activities under hypoxic conditions. It was demonstrated that hypoxia stimulates migration and invasion in MG63 cells, which was correlated with the downregulation of miR-15a and upregulation of B-cell lymphoma 2 (Bcl-2) expression. Introduction of miR-15a or knockdown of endogenous Bcl-2 may reduce hypoxia-induced cell invasion and migration through the regulation of matrix metalloproteinases. Analysis of the expression of miR-15a indicated that hypoxia repressed the transcription of deleted in lymphocytic leukemia 2 (DLEU2), which is the host gene of miR-15a. These findings indicated that miR-15a may be a valuable target for the treatment of osteosarcoma, particularly for patients with high-grade cancer or heavy tumor burden.
机译:骨肉瘤是一种常见的高危原发性骨恶性肿瘤,主要影响年轻人口。迄今为止,骨肉瘤患者的临床结局没有显着改善,并且癌症复发和转移在高级别骨肉瘤中很常见。因此,鉴定新的生物标志物和新的治疗靶标对于改善骨肉瘤患者的预后至关重要。在本研究中,MG63人骨肉瘤细胞系用于检查低氧条件下microRNA(miR)-15a在调节细胞活性中的作用。结果表明,缺氧会刺激MG63细胞迁移和侵袭,这与miR-15a的下调和B细胞淋巴瘤2(Bcl-2)表达的上调相关。 miR-15a的引入或内源性Bcl-2的敲低可通过调节基质金属蛋白酶减少缺氧诱导的细胞侵袭和迁移。对miR-15a表达的分析表明,低氧抑制了miR-15a的宿主基因淋巴细胞白血病2(DLEU2)中的缺失转录。这些发现表明,miR-15a可能是治疗骨肉瘤的重要靶标,特别是对于患有高级别癌症或重肿瘤的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号